Finance

Lists
DIVISLAB:NSE
Divi's Laboratories Ltd
₹11,442.00
-0.37%
(-43.00) 1D
Nov 13, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for DIVISLAB...
Open
₹11,411.50
High
₹11,645.50
Low
₹11,350.50
Mkt. cap
3.04T
Avg. vol.
739.46K
Volume
536.55K
Dividend
0.26%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
90.30
52-wk high
₹11,824.00
52-wk low
₹5,647.50
EPS
₹126.72
Shares outstanding
265.47M
No. of employees
12K
Open
₹11,411.50
High
₹11,645.50
Low
₹11,350.50
Mkt. cap
3.04T
Avg. vol.
739.46K
Volume
536.55K
Dividend
0.26%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
90.30
52-wk high
₹11,824.00
52-wk low
₹5,647.50
EPS
₹126.72
Shares outstanding
265.47M
No. of employees
12K
News stories
From web sources and news partners
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11.6K
FoundedOct 12, 1990
Headquarters-
SectorHealth Care
Industry-
Last report
Nov 7, 2026
Fiscal period
Q2 2027
₹42.49 / ₹31.94
+33.04%beat
Revenue / Est. (INR)
36.76B / 31.97B
+14.97%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
26.04B
28.31B
30.80B
36.76B
Cost of goods sold
9.45B
13.49B
9.86B
11.81B
Cost of revenue
9.45B
13.49B
9.86B
11.81B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.67B
3.99B
4.08B
4.44B
Operating expense
8.87B
6.68B
9.65B
10.71B
Total operating expenses
18.32B
20.17B
19.51B
22.52B
Operating income
7.72B
8.14B
11.29B
14.24B
Other non operating income
690.00M
-2.23B
640.00M
700.00M
EBT including unusual items
7.80B
9.63B
11.80B
15.05B
EBT excluding unusual items
8.54B
9.59B
11.80B
15.05B
Income tax expense
1.97B
2.12B
2.78B
3.78B
Effective tax rate
25.26%
22.01%
23.56%
25.12%
Other operating expenses
4.02B
1.49B
4.24B
4.85B
Net income
5.83B
7.51B
9.02B
11.27B
Net profit margin
22.39%
26.53%
29.29%
30.66%
Earnings per share
24.07
28.31
33.95
42.49
Interest and investment income
-
2.84B
-
-
Interest expense
-60.00M
-60.00M
-60.00M
-130.00M
Net interest expenses
-60.00M
2.78B
-60.00M
-130.00M
Depreciation and amortization charges
1.18B
1.20B
1.33B
1.42B
EBITDA
8.72B
9.29B
12.44B
15.62B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps